SIGHT SCIENCES, INC. Interest Expense
SIGHT SCIENCES, INC. (SGHT) reported Interest Expense of $1.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-05
- SIGHT SCIENCES, INC. interest expense for the quarter ending 2026-06-30 was $1.29M, a 0.47% increase year-over-year.
- SIGHT SCIENCES, INC. interest expense for the quarter ending 2026-03-31 was $1.27M, a 0.40% increase year-over-year.
- SIGHT SCIENCES, INC. interest expense for the quarter ending 2025-12-31 was $1.29M, a 11.02% increase year-over-year.
- SIGHT SCIENCES, INC. interest expense for the quarter ending 2025-09-30 was $1.31M, a 13.47% increase year-over-year.
- SIGHT SCIENCES, INC. interest expense for fiscal 2025 was $5.14M, a 10.30% increase from fiscal 2024.
- SIGHT SCIENCES, INC. interest expense for fiscal 2024 was $4.66M, a 13.79% decline from fiscal 2023.
- SIGHT SCIENCES, INC. interest expense for fiscal 2023 was $5.41M, a 21.09% increase from fiscal 2022.
- SIGHT SCIENCES, INC. interest expense for fiscal 2022 was $4.47M, a 2.29% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.29M 10-Q · filed 2026-08-05 | $2.56M 10-Q · filed 2026-08-05 | $3.85M derived: sum of 3 quarters · filed 2026-08-05 | $5.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-06 | $2.56M derived: sum of 2 quarters · filed 2026-05-06 | $3.86M derived: sum of 3 quarters · filed 2026-05-06 | $5.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.60M derived: sum of 2 quarters · filed 2026-03-04 | $3.88M derived: sum of 3 quarters · filed 2026-08-05 | $5.14M 10-K · filed 2026-03-04 |
| 2025-09-30 | $1.31M 10-Q · filed 2025-11-06 | $2.59M derived: sum of 2 quarters · filed 2026-08-05 | $3.85M 10-Q · filed 2025-11-06 | $5.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.28M 10-Q · filed 2026-08-05 | $2.55M 10-Q · filed 2026-08-05 | $3.71M derived: sum of 3 quarters · filed 2026-08-05 | $4.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.26M 10-Q · filed 2026-05-06 | $2.42M derived: sum of 2 quarters · filed 2026-05-06 | $3.58M derived: sum of 3 quarters · filed 2026-05-06 | $4.72M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.31M derived: sum of 2 quarters · filed 2026-03-04 | $3.46M derived: sum of 3 quarters · filed 2026-03-04 | $4.66M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.15M 10-Q · filed 2025-11-06 | $2.30M derived: sum of 2 quarters · filed 2025-11-06 | $3.50M 10-Q · filed 2025-11-06 | $4.85M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.15M 10-Q · filed 2025-08-07 | $2.35M 10-Q · filed 2025-08-07 | $3.70M derived: sum of 3 quarters · filed 2025-08-07 | $5.13M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.20M 10-Q · filed 2025-05-08 | $2.56M derived: sum of 2 quarters · filed 2025-05-08 | $3.99M derived: sum of 3 quarters · filed 2025-05-08 | $5.34M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.78M derived: sum of 2 quarters · filed 2025-03-07 | $4.13M derived: sum of 3 quarters · filed 2025-03-07 | $5.41M 10-K · filed 2025-03-07 |
| 2023-09-30 | $1.43M 10-Q · filed 2024-11-07 | $2.78M derived: sum of 2 quarters · filed 2024-11-07 | $4.06M 10-Q · filed 2024-11-07 | $5.28M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.35M 10-Q · filed 2024-08-02 | $2.63M 10-Q · filed 2024-08-02 | $3.85M derived: sum of 3 quarters · filed 2024-08-02 | $4.98M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $1.28M 10-Q · filed 2024-05-06 | $2.50M derived: sum of 2 quarters · filed 2024-05-06 | $3.63M derived: sum of 3 quarters · filed 2024-05-06 | $4.70M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.35M derived: sum of 2 quarters · filed 2024-03-13 | $3.42M derived: sum of 3 quarters · filed 2024-03-13 | $4.47M 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.13M 10-Q · filed 2023-11-07 | $2.20M derived: sum of 2 quarters · filed 2023-11-07 | $3.24M 10-Q · filed 2023-11-07 | $4.32M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.06M 10-Q · filed 2023-08-07 | $2.11M 10-Q · filed 2023-08-07 | $3.19M derived: sum of 3 quarters · filed 2023-08-07 | $4.31M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $1.05M 10-Q · filed 2023-05-08 | $2.12M derived: sum of 2 quarters · filed 2023-05-08 | $3.25M derived: sum of 3 quarters · filed 2023-05-08 | $4.33M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $2.20M derived: sum of 2 quarters · filed 2023-03-16 | $3.28M derived: sum of 3 quarters · filed 2023-03-16 | $4.37M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.12M 10-Q · filed 2022-11-10 | $2.20M derived: sum of 2 quarters · filed 2022-11-10 | $3.29M 10-Q · filed 2022-11-10 | $4.05M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.08M 10-Q · filed 2022-08-11 | $2.17M 10-Q · filed 2022-08-11 | $2.93M derived: sum of 3 quarters · filed 2022-08-11 | $3.47M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.08M 10-Q · filed 2022-05-10 | $1.85M derived: sum of 2 quarters · filed 2022-05-10 | $2.39M derived: sum of 3 quarters · filed 2022-05-10 | $2.94M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.30M derived: sum of 2 quarters · filed 2022-03-24 | $1.85M derived: sum of 3 quarters · filed 2022-03-24 | $2.40M 10-K · filed 2022-03-24 |
| 2020-09-30 | $538.00K 10-Q · filed 2021-11-10 | $1.09M derived: sum of 2 quarters · filed 2021-11-10 | $1.64M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $549.00K 10-Q · filed 2021-08-12 | $1.10M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |